“…In these cases, the screen aims to identify genes belonging to a pre-determined set of interacting genes. Some examples of successful screens aiming to identify members of known signalling pathways are those targeting the Sevenless and EGFR (Karim et al, 1996;Huang and Rubin, 2000;Taguchi et al, 2000;Rebay et al, 2000), Notch (Verheyen et al, 1996;Go and Artavanis-Tsakonas, 1998;Muller et al, 2005a), Dpp (Raftery et al, 1995;Chen et al, 1998;Su et al, 2001), JAK/STAT (Bach et al, 2003;Mukherjee et al, 2006), Hh (Haines and van den Heuvel, 2000;Collins and Cohen, 2005), TNF (Geuking et al, 2005) and Wnt (Greaves et al, 1999;Cox et al, 2000;Desbordes et al, 2005) pathways. Although the use of genetic screens in vivo has many advantages, they are time-consuming and difficult to escalate genome-wide.…”